Showing results (931-940 of 1,051) with videos related to

Sort By:
Pageof 106
ACS Medicinal Chemistry Letters|November 20, 2024
Studies of Structure-Activity Relationship of 2-(Pyrrolidin-1ylmethyl)-1<i>H</i>-pyrrole-Based ST2 Inhibitors and Their Inhibition of Mast Cells ActivationXinrui Yuan, Jason C Rech, Andhavaram Ramaraju, et al.
Clinical Chemistry|December 10, 2016
Universal Haplotype-Based Noninvasive Prenatal Testing for Single Gene DiseasesWinnie W I Hui, Peiyong Jiang, Yu K Tong, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 26, 2021
Genome-wide detection of cytosine methylation by single molecule real-time sequencingO Y Olivia Tse, Peiyong Jiang, Suk Hang Cheng, et al.
Open Forum Infectious Diseases|June 10, 2025
Sequencing HIV Diagnostic Samples to Detect Genetic Clusters and Assess Sequence Coverage GapsCara J Broshkevitch, Shuntai Zhou, Annalea Greifinger, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2014
Plasma DNA aberrations in systemic lupus erythematosus revealed by genomic and methylomic sequencingRebecca W Y Chan, Peiyong Jiang, Xianlu Peng, et al.
Neurosurgery|June 16, 2023
Neurological Examination Frequency and Time-to-Delirium After Traumatic Brain InjurySilky Chotai, Jeffrey W Chen, Robert Turer, et al.
Plos One|March 27, 2018
Tuberculosis during pregnancy in the United States: Racial/ethnic disparities in pregnancy complications and in-hospital deathErika M Dennis, Yun Hao, Mabella Tamambang, et al.
Diabetes Care|February 2, 2018
Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-term Glycemic Response to DPP-4 Inhibitor TherapyJohn M Dennis, Beverley M Shields, Anita V Hill, et al.
Clinical Chemistry|October 17, 2009
Aberrant concentrations of liver-derived plasma albumin mRNA in liver pathologiesRebecca W Y Chan, John Wong, Henry L Y Chan, et al.
Medrxiv : the Preprint Server for Health Sciences|May 3, 2023
Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitorsKatherine G Young, Eram Haider McInnes, Robert J Massey, et al.
Pageof 106